EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia

Raquel Real iD, Alejandro Martinez-Carrasco iD, Regina H Reynolds iD, Michael A Lawton iD, Manuela M X Tan iD, Maryam Shoai iD, Jean-Christophe Corvol iD, Mina Ryten iD, Catherine Bresner iD, Leon Hubbard iD, Alexis Brice iD, Suzanne Lesage iD und 9 weitere

Brain · 02.05.2023 · 146 (5) · 1873-1887

DOI: 10.1093/brain/awac414 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Brain, online erschienen am 09.11.2022. Verfasst von Raquel Real und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Dementia, Cognitive Dysfunction. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, Parkinson's UK, Aligning Science Across Parkinson’s.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease is one of the most common age-related neurodegenerative disorders. Although predominantly a motor disorder, cognitive impairment and dementia are important features of Parkinson’s disease, particularly in the later stages of the disease. However, the rate of cognitive decline varies among Parkinson’s disease patients, and the genetic basis for this heterogeneity is incompletely understood. To explore the genetic factors associated with rate of progression to Parkinson’s disease dementia, we performed a genome-wide survival meta-analysis of 3923 clinically diagnosed Parkinson’s disease cases of European ancestry from four longitudinal cohorts. In total, 6.7% of individuals with Parkinson’s disease developed dementia during study follow-up, on average 4.4 ± 2.4 years from disease diagnosis. We have identified the APOE ε4 allele as a major risk factor for the conversion to Parkinson’s disease dementia [hazard ratio = 2.41 (1.94–3.00), P = 2.32 × 10−15], as well as a new locus within the ApoE and APP receptor LRP1B gene [hazard ratio = 3.23 (2.17–4.81), P = 7.07 × 10−09]. In a candidate gene analysis, GBA variants were also identified to be associated with higher risk of progression to dementia [hazard ratio = 2.02 (1.21–3.32), P = 0.007]. CSF biomarker analysis also implicated the amyloid pathway in Parkinson’s disease dementia, with significantly reduced levels of amyloid β42 (P = 0.0012) in Parkinson’s disease dementia compared to Parkinson’s disease without dementia. These results identify a new candidate gene associated with faster conversion to dementia in Parkinson's disease and suggest that amyloid-targeting therapy may have a role in preventing Parkinson’s disease dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDementiaCognitive DysfunctionHumansApolipoproteins EBiomarkersReceptors, LDL

Stichwörter der Autor:innen

Parkinson’s diseasedementiagenome-widesurvival

Substanzen

Apolipoproteins EBiomarkersLRP1B protein, humanReceptors, LDL

Autor:innen und Institutionen

  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • UCL Movement Disorders Centre, University College London, London WC1N 3BG, UK.
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.
  • Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK.
  • Department of Neurology, Oslo University Hospital, 0424 Oslo, Norway.

ORCID-Profile: Raquel Real, Alejandro Martinez-Carrasco, Regina H Reynolds, Michael A Lawton, Manuela M X Tan, Maryam Shoai, Jean-Christophe Corvol, Mina Ryten, Catherine Bresner, Leon Hubbard, Alexis Brice, Suzanne Lesage, Johann Faouzi, Alexis Elbaz, Nigel Williams, Michele T M Hu, Yoav Ben-Shlomo, Donald G Grosset, John Hardy, Huw R Morris

Förderung

  • Medical Research Council
  • Parkinson's UK
  • Aligning Science Across Parkinson’s
  • Michael J. Fox Foundation

Zitieren

APA

Real, R., Martinez-Carrasco, A., Reynolds, R. H., Lawton, M. A., Tan, M. M. X., Shoai, M., Corvol, J. C., Ryten, M., Bresner, C., Hubbard, L., Brice, A., Lesage, S., Faouzi, J., Elbaz, A., Artaud, F., Williams, N., Hu, M. T. M., Ben-Shlomo, Y., Grosset, D. G., …, & Morris, H. R. (2023). Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia. Brain, 146(5), 1873-1887. https://doi.org/10.1093/brain/awac414

Vancouver

Real R, Martinez-Carrasco A, Reynolds RH, Lawton MA, Tan MMX, Shoai M, et al. Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia. Brain. 2023;146(5):1873-1887. doi:10.1093/brain/awac414

BibTeX
@article{Real2023,
  author = {Real, Raquel and Martinez-Carrasco, Alejandro and Reynolds, Regina H and Lawton, Michael A and Tan, Manuela M X and Shoai, Maryam and Corvol, Jean-Christophe and Ryten, Mina and Bresner, Catherine and Hubbard, Leon and Brice, Alexis and Lesage, Suzanne and Faouzi, Johann and Elbaz, Alexis and Artaud, Fanny and Williams, Nigel and Hu, Michele T M and Ben-Shlomo, Yoav and Grosset, Donald G and Hardy, John and Morris, Huw R},
  title = {Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {5},
  pages = {1873--1887},
  doi = {10.1093/brain/awac414}
}
Kostenlos starten →